Herspiegel brings experience, innovation, and strategic acumen to building winning market access strategies for clients’ new and inline products. Our deep US and global expertise and broad set of tools and solutions—supported by our extensive stakeholder network and industry partnerships—enables us to deliver precise insights into brands’ market access opportunities and the strategies clients need to realize them.
Our industry-leading Market Access Practice team provides clients with the insights and expertise to build and implement access strategies that align price with product value and effectively communicate that value to stakeholders. By helping overcome the barriers that patients encounter in their access journeys, Herspiegel enables our clients to realize brand goals.
Recommended clinical and economic endpoints and treatment positioning needed to optimize access in EU5 and US for a novel compound.
Developed channel-specific value propositions for new products that reflect real-world assessments of efficacy and clinical improvement.
Provided a detailed pre-launch road map for a new asset for an ultra-rare pediatric condition that identified the access stakeholders to engage and the information to provide to ensure product utilization at launch.
Recommended a distribution model that minimized client’s costs, while addressing the needs of patients and customers for seamless product experience.
Developed and planned implementation of an IDN engagement strategy based on population health management capabilities.
Designed outcomes-based contracting strategy for a novel pain product and provided implementation playbook for client field team.
Recommended patient copay support program based on analog assessment and quantitative modeling, equipping client with comprehensive and easy-to-use scenario evaluation model.
Developed and implemented key account business planning process that improved account engagement as well as internal alignment and communication regarding goals, strategies and plans related to top accounts across market access channels.
How do copay accumulators work and what can brand leaders do about them? Read our white paper outlining how these programs may actually increase the costs to patients, causing them to abandon scripts, skip doses, or switch medications.
